by Sue Brown, CEO ARMA
We all know that people are waiting too long for a variety of MSK treatment in the NHS. We all know that the NHS is working hard to tackle waiting times with some success. However, the patient’s experience of waiting and the NHS understanding can be very different things. If the NHS is to deal with waiting lists well, then I would argue it needs to understand what waiting means to patients.
The GIRFT rheumatology Further Faster programme invited me to speak about this to their meeting last night.…
Read more of this article